IDEXX Laboratories, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15505
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

IDEXX Laboratories, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

IDEXX Laboratories, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

IDEXX Laboratories (IDEXX or ‘the company’) is engaged in the provision of diagnostics and information technology solutions for animal health, water testing and dairy markets. The company operates in the Americas, Europe, Asia Pacific, the Middle East and Africa. IDEXX is headquartered in Westbrook, Maine.

Scope

- Detailed information on IDEXX Laboratories, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting IDEXX Laboratories, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of IDEXX Laboratories, Inc. including a breakdown and examination of key business segments
- Intelligence on IDEXX Laboratories, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about IDEXX Laboratories, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of IDEXX Laboratories, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess IDEXX Laboratories, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on IDEXX Laboratories, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
IDEXX Laboratories, Inc.: Company Overview
IDEXX Laboratories, Inc.: Overview and Key Facts
IDEXX Laboratories, Inc.: Overview
IDEXX Laboratories, Inc.: Key Facts
IDEXX Laboratories, Inc.: Key Employees
IDEXX Laboratories, Inc.: Key Employee Biographies
IDEXX Laboratories, Inc.: Major Products and Services
IDEXX Laboratories, Inc.: Company History
IDEXX Laboratories, Inc.: Management Statement
IDEXX Laboratories, Inc.: Locations and Subsidiaries
IDEXX Laboratories, Inc.: Key Competitors
IDEXX Laboratories, Inc.: Company Analysis
IDEXX Laboratories, Inc.: Business Description
IDEXX Laboratories, Inc.: SWOT Analysis
IDEXX Laboratories, Inc.: SWOT Overview
IDEXX Laboratories, Inc.: Strengths
IDEXX Laboratories, Inc.: Weaknesses
IDEXX Laboratories, Inc.: Opportunities
IDEXX Laboratories, Inc.: Threats
IDEXX Laboratories, Inc.: Corporate Financial Deals Activity
IDEXX Laboratories, Inc.: Financial Deals Overview
IDEXX Laboratories, Inc.: Targets and Partners
IDEXX Laboratories, Inc.: Top Deals 2015 – 2019YTD*
IDEXX Laboratories, Inc.: Mergers and Acquisitions
IDEXX Laboratories, Inc.: Recent Developments
IDEXX Laboratories, Inc.: News and Events Summary
IDEXX Laboratories, Inc.: Contracts
IDEXX Laboratories, Inc.: Financial Performance
IDEXX Laboratories, Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: IDEXX Laboratories, Inc.: Key Facts
Table 2: IDEXX Laboratories, Inc.: Key Employees
Table 3: IDEXX Laboratories, Inc.: Company History
Table 4: IDEXX Laboratories, Inc.: Locations and Subsidiaries
Table 5: IDEXX Laboratories, Inc.: Key Competitors
Table 6: IDEXX Laboratories, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: IDEXX Laboratories, Inc.: M&A Activity by Geography (TTM*)
Table 8: IDEXX Laboratories, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: IDEXX Laboratories, Inc.: Targets and Partners
Table 10: IDEXX Laboratories, Inc.: Top Deals 2015 - 2019YTD*
Table 11: IDEXX Laboratories, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: IDEXX Laboratories, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 13: IDEXX Laboratories, Inc.: News and Events Summary
Table 14: IDEXX Laboratories, Inc.: Contracts
Table 15: IDEXX Laboratories, Inc.: Financial Performance
Table 16: IDEXX Laboratories, Inc.: Regulatory and Legal Events

List of Figures
Figure 1: IDEXX Laboratories, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: IDEXX Laboratories, Inc.: M&A Activity by Geography (TTM*)
Figure 3: IDEXX Laboratories, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: IDEXX Laboratories, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: IDEXX Laboratories, Inc.: M&A Activity by Geography (2015 - YTD*2019)

★海外企業調査レポート[IDEXX Laboratories, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Olam International Ltd:戦略・SWOT・企業財務分析
    Olam International Ltd - Strategy, SWOT and Corporate Finance Report Summary Olam International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nurix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Malayan Banking Berhad:企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Ardian Holding SAS:企業の戦略的SWOT分析
    Ardian Holding SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • Advanced Accelerator Applications SA (AAAP):企業の財務・戦略的SWOT分析
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Vistin Pharma AS (VISTIN)-製薬・医療分野:企業M&A・提携分析
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies solid dosage forms and active pharmaceutical ingredients. The company’s products include metformin, an API for the treatment of diabetes II; opioids, an analgesics and antitussive; …
  • Naia Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Naia Ltd (Naia) is a funding and developing company that address regional and global medical needs. The company develops and manufactures therapeutics for metabolic and rare diseases. It provides global drug development through funding, clinical development, organizational structure and regu …
  • Ecolab Inc (ECL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecolab Inc (Ecolab) provides water, hygiene and energy technologies and services. It offers solutions and services such as cleaning and sanitizing programs and products, pest elimination services, and equipment maintenance and repair services. The company caters to foodservice, food and beve …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Teva Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceuticals USA Inc (Teva Pharmaceuticals), formerly Lemmon Pharmacal Company, a subsidiary of Teva Pharmaceutical Industries Ltd, is a developer and manufacturer of pharmaceutical ingredients. The company’s products include antiulcer agents and acid suppressants, antiviral capsules …
  • Ellomay Capital Ltd (ELLO):企業の財務・戦略的SWOT分析
    Summary Ellomay Capital Ltd (Ellomay), formerly NUR Macroprinters Ltd, is an energy and infrastructure consulting company that provides renewable energy, oil and gas exploration, and clean energy solutions. The company offers renewable energy services such as installation of photovoltaic plants, man …
  • Geisinger Health System-製薬・医療分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …
  • First Ship Lease Trust (D8DU):企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Solocal Group (LOCAL):企業の財務・戦略的SWOT分析
    Solocal Group (LOCAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析
    Summary Auven Therapeutics Management LLLP (Auven Therapeutics Management), formerly Celtic Therapeutics Management LLLP is a private equity firm that provides life science investment strategy. The firm invests in therapeutic products or platforms. It has invested in diversified portfolio of biologi …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, PMX, SAMI, toraymyxin and reagents. Its EAA is an endotoxin activity assay, which …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆